Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Colorectal Neoplasms and BID[original query] |
---|
Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin. Cancer chemotherapy and pharmacology 2009 Oct 64 (5): 953-60. Kim Jong Gwang, Chae Yee Soo, Sohn Sang Kyun, Moon Joon Ho, Ryoo Hun Mo, Bae Sung Hwa, Kum Yoonseop, Jeon Seong Woo, Lim Kyoung-Hoon, Kang Byung-Mo, Park In-Ja, Choi Gyu Seog, Jun Soo-H |
Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis. Cancer chemotherapy and pharmacology 2011 Jun 67 (6): 1323-31. Hong Junshik, Han Sae-Won, Ham Hye Seon, Kim Tae-Yong, Choi In Sil, Kim Byung-Su, Oh Do-Youn, Im Seock-Ah, Kang Gyeong Hoon, Bang Yung-Jue, Kim Tae-Y |
Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis. British journal of cancer 2010 Mar 102 (6): 987-94. Zarate R, Rodríguez J, Bandres E, Patiño-Garcia A, Ponz-Sarvise M, Viudez A, Ramirez N, Bitarte N, Chopitea A, Gacía-Foncillas |
Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer. Cancer chemotherapy and pharmacology 2013 Nov 72 (5): 953-64. Park Sook Ryun, Hong Yong Sang, Lim Hyeong-Seok, Seong Moon-Woo, Kong Sun-Young, Kim Sun Young, Park Young-Iee, Jung Kyung H |
Correlation of hypertension and proteinuria with outcome in elderly bevacizumab-treated patients with metastatic colorectal cancer. PloS one 2015 1 10 (1): e0116527. Feliu Jaime, Salud Antonieta, Safont Maria J, García-Girón Carlos, Aparicio Jorge, Losa Ferran, Bosch Carlos, Escudero Pilar, Casado Enrique, Jorge Monica, Bohn Uriel, Pérez-Carrión Ramon, Carmona Alberto, Custodio Ana B, Maurel Jo |
A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101). International journal of clinical oncology 2017 Oct 22 (5): 913-920. Ando Koji, Emi Yasunori, Suenaga Toyokuni, Hamanoue Masahiro, Maekawa Soichiro, Sakamoto Yasuo, Kai Seiichiro, Satake Hironaga, Shimose Takayuki, Shimokawa Mototsugu, Saeki Hiroshi, Oki Eiji, Sakai Kenji, Akagi Yoshito, Baba Hideo, Maehara Yoshihiko, |
Pre-Existing Tumoral B Cell Infiltration and Impaired Genome Maintenance Correlate with Response to Chemoradiotherapy in Locally Advanced Rectal Cancer. Cancers 2020 8 12 (8): . Sendoya Juan M, Iseas Soledad, Coraglio Mariana, Golubicki Mariano, Robbio Juan, Salanova Ruben, Kujaruk Mirta, Mikolaitis Vanesa, Rizzolo Mariana, Ruiz Gonzalo, Cabanne Ana, Gualdrini Ubaldo, Mendez Guillermo, Hirmas Stella, Rotondaro Cecilia, Viglino Julieta, Eleta Martín, Fernandez Elmer, Abba Martín, Podhajcer Osvaldo, Roca Enrique, Llera Andrea |
Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu 2020 Jun 32 (3): 370-382. Li Huiping, Liu Rongrui, Shao Bin, Ran Ran, Song Guohong, Wang Ke, Shi Yehui, Liu Jihong, Hu Wenjing, Chen Fu, Liu Xiaoran, Zhang Gairong, Zhao Chuanhua, Jia Ru, Wang Quanren, Rugo Hope S, Zhang Yifan, Li Guangze, Xu Jianmi |
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic Cancer. The oncologist 2020 12 26 (4): 290-e545. van Brummelen Emilie M J, Huijberts Sanne, van Herpen Carla, Desar Ingrid, Opdam Frans, van Geel Robin, Marchetti Serena, Steeghs Neeltje, Monkhorst Kim, Thijssen Bas, Rosing Hilde, Huitema Alwin, Beijnen Jos, Bernards Rene, Schellens J |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source: